Inborn errors of immunity may not always be easy to recognize, but rheumatologists should look out for them. Dr. Bharat Kumar shares his insights.
Search results for: Primary care
Abatacept Shows Promise for Some Myositis Patients
Injected abatacept may be a worthwhile treatment for certain patients with idiopathic inflammatory myositis (IIM), according to recent research.1 Patients with the rare autoimmune conditions involving inflammation of muscle (myositis) and other organ systems suffer widespread organ dysfunction, increased morbidity, physical disabilities and early death. Symptoms vary by subtype. For example, dermatomyositis (DM) involves muscle…
President’s Corner: How to Stay on Top of ACR/ARP News
When speaking to ACR and ARP members, people are always interested in hearing about the most recent news coming out of the ACR, specifically in areas of interest to them and their patients. It was these discussions that prompted me to make enhancing connections and communications between the ACR and its members one of my…
Can Stem Cell Transplantation Improve Survival Rates in Patients with Systemic Sclerosis?
Autologous hematopoietic stem cell transplantation (AHSCT) may improve the survival rate of patients with diffuse cutaneous systemic sclerosis (SSc), according to Georges et al. The single-arm clinical trial demonstrated the effectiveness of AHSCT and maintenance therapy. Researchers also identified potential risk factor of AHSCT in patients with low eGFR before transplantation.
A Passion for Research
With three new endowments established, the ACR Rheumatology Research Foundation aims to support and inspire the future of rheumatology and the innovative research that will one day benefit patients.
Cannabis for Pain Management in Rheumatology
‘Cannabis has a long history of being used for pain management,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘What does it mean for rheumatology patients moving forward? Read our article for one answer to this question.’ As cannabis becomes more widely legalized, both in the U.S. and internationally, its use for pain…
Potential Biologic Drug Treatment for IgG4-RD Identified
Inebilizumab reduces the risk of immunoglobulin G4-related disease (IgG4-RD) flares and increases the likelihood of flare-free, complete remission at one year, a recent study shows.1 The randomized, doubleblind, placebo-controlled MITIGATE trial showed that inebilizumab reduced the risk of IgG4-RD symptoms by 87%, compared with placebo. About IgG4-RD IgG4-RD is chronic, rare condition that has, so…
A&R Editor-in-Chief Daniel H. Solomon, MD, MPH, Reflects on the Journal, His Role & Its Future
New clinical features, opinion pieces and much more—outgoing Arthritis & Rheumatology Editor-in-Chief Daniel H. Solomon, MD, MPH, discusses how the journal has evolved and where it’s going.
Insights into ACR Open Rheumatology
ACR Open Rheumatology Editor-in-Chief Andras Perl, MD, PhD, discusses his unique career and his approach to balancing basic and translational research articles with outcome-focused articles within the journal.
Clinical Research & Practice with AC&R Editor-in-Chief Dr. Kelli Allen
Arthritis Care & Research (AC&R), a peer-reviewed journal published monthly, comprises original research, review articles and editorials that “move clinical research and practice forward in a meaningful way,” according to AC&R Editor-in-Chief Kelli D. Allen, PhD. That includes research on evidence-based practice; clinical problems; practice guidelines; educational, social, and public health issues; health economics and…
- « Previous Page
- 1
- …
- 63
- 64
- 65
- 66
- 67
- …
- 137
- Next Page »